These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11758536)

  • 1. Frontiers in MMP (matrix metalloproteinases) and ADAMs (a disintegrin and metalloproteinase) research. October 17-19, 2001. Tokyo, Japan. Abstracts.
    Keio J Med; 2001 Oct; 50 Suppl 3():1-91. PubMed ID: 11758536
    [No Abstract]   [Full Text] [Related]  

  • 2. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
    Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
    Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
    Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
    J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension.
    Lepetit H; Eddahibi S; Fadel E; Frisdal E; Munaut C; Noel A; Humbert M; Adnot S; D'Ortho MP; Lafuma C
    Eur Respir J; 2005 May; 25(5):834-42. PubMed ID: 15863640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
    Hara I; Miyake H; Hara S; Arakawa S; Kamidono S
    J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging.
    Vigetti D; Moretto P; Viola M; Genasetti A; Rizzi M; Karousou E; Pallotti F; De Luca G; Passi A
    FASEB J; 2006 Jun; 20(8):1118-30. PubMed ID: 16770011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development.
    Huh MI; Lee YM; Seo SK; Kang BS; Chang Y; Lee YS; Fini ME; Kang SS; Jung JC
    J Cell Biochem; 2007 Aug; 101(5):1222-37. PubMed ID: 17295208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets.
    Berthier CC; Lods N; Joosten SA; van Kooten C; Leppert D; Lindberg RL; Kappeler A; Raulf F; Sterchi EE; Lottaz D; Marti HP
    Kidney Int; 2006 Jan; 69(2):358-68. PubMed ID: 16408127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
    Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS
    Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of interleukin 6 (IL-6)/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase/extracellular.
    Legendre F; Bogdanowicz P; Boumediene K; Pujol JP
    J Rheumatol; 2005 Jul; 32(7):1307-16. PubMed ID: 15996070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
    Nie J; Pei D
    Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function.
    Lindsey ML; Goshorn DK; Squires CE; Escobar GP; Hendrick JW; Mingoia JT; Sweterlitsch SE; Spinale FG
    Cardiovasc Res; 2005 May; 66(2):410-9. PubMed ID: 15820210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
    Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
    Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis.
    Kanwar YS; Ota K; Yang Q; Wada J; Kashihara N; Tian Y; Wallner EI
    Am J Physiol; 1999 Dec; 277(6):F934-47. PubMed ID: 10600941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Roles of matrix metalloproteinases and tissue inhibitor of metalloproteinase (TIMP) in cancer invasion and metastasis].
    Okada A
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2247-52. PubMed ID: 10635313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes.
    Kouwenhoven M; Ozenci V; Gomes A; Yarilin D; Giedraitis V; Press R; Link H
    J Autoimmun; 2001 Jun; 16(4):463-70. PubMed ID: 11437495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
    Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
    Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.